Back
IDEX Corp. 10K Form
Buy
59
IEX
IDEX Corp.
Last Price:
$179.07
Seasonality Move:
3.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-26 | 10Q | IEX/IDEX Corp. Quarterly |
| 2023-07-27 | 10Q | IEX/IDEX Corp. Quarterly |
| 2023-04-27 | 10Q | IEX/IDEX Corp. Quarterly |
| 2022-10-26 | 10Q | IEX/IDEX Corp. Quarterly |
| 2022-07-27 | 10Q | IEX/IDEX Corp. Quarterly |
| 2022-04-27 | 10Q | IEX/IDEX Corp. Quarterly |
Receive IEX News And Ratings
See the #1 stock for the next 7 days that we like better than IEX
IEX Financial Statistics
Sales & Book Value
| Annual Sales: | $3.3B |
|---|---|
| Cash Flow: | $188.7M |
| Price / Cash Flow: | 23.07 |
| Annual Sales: | $53.49 |
| Price / Book: | 3.33 |
Profitability
| EPS (TTM): | 6.32560 |
|---|---|
| Net Income (TTM): | $477.4M |
| Gross Margin: | $1.5B |
| Return on Equity: | 12.22% |
| Return on Assets: | 6.95% |
IDEX Corp. Earnings Forecast
Key IDEX Corp. Financial Ratios
-
The Gross Profit Margin over the past 37 years for IEX is 46.40%.
-
The Selling, General & Administrative Expenses for IEX have been equal to 23.21% of Gross Profit Margin.
-
The Research & Development expenses have been 5.46% of Revenue.
-
The Interest Expense is 8.82% of Operating Income.
-
The Net Earning history of IEX is 15.44% of Total Revenues.
-
Per Share Earnings over the last 37 years have been positive in 21 years.
IDEX Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Machinery |
| Sector: | Industrials |
| Current Symbol: | IEX |
| CUSIP: | 45167R |
| Website: | idexcorp.com |
Debt
| Debt-to-Equity Ratio: | 0.48 |
|---|---|
| Current Ratio: | 2.93 |
| Quick Ratio: | 1.92 |
Price-to-Earnings
| Trailing P/E Ratio: | 26.78 |
|---|---|
| Forward P/E Ratio: | 21.4 |
IEX Technical Analysis vs Fundamental Analysis
Buy
59
IDEX Corp. (IEX)
is a Buy
Is IDEX Corp. a Buy or a Sell?
-
IDEX Corp. stock is rated a BuyThe current IDEX Corp. [IEX] share price is $178.21. The Score for IEX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.